C4C
Adjunctive Clindamycin For Cellulitis: Clinical trial comparing
flucloxacillin with or without clindamycin for the treatment of
limb cellulitis (C4C Trial)
Chief Investigator
|
Institution
|
Dates
|
Funding Stream
|
Grant Ref
|
Amount
|
Dr Richard Brindle
|
University Hospitals Bristol NHS Foundation Trust
|
01/08/2013 - 30/09/2015
(24 months)
+ 2 months
|
NIHR Research for Patient Benefit (RfPB)
|
PB-PG-0212-27015
|
£249,404
|
Summary
Cellulitis is very common and some people can get it more than
once. It can make people feel very ill and the streptococcus
bacterium causing cellulitis produces a variety of poisons or
'toxins' which damage the skin. The normal treatment is with an
antibiotic called flucloxacillin, which is effective. Another
antibiotic called clindamycin is often used to treat a more serious
infection, caused by the same bacterium, called necrotising
fasciitis. This antibiotic is also sometimes added to, or used
after, flucloxacillin if the cellulitis does not appear to be
getting better. Clindamycin is added because some doctors think
that it will reduce the amount of toxins released by the bacterium.
If less toxin is released then there should be less skin damage. So
we thought that if we added clindamycin to the normal
flucloxacillin treatment of cellulitis it might reduce the amount
of skin damage. If the amount of skin damage was less then the
patient would have less pain and should have recovered more
quickly. We wanted to give clindamycin to half our patients who had
cellulitis together with flucloxacillin and just give
flucloxacillin to the other half. We would then see which patients
get better more quickly. Clindamycin can sometimes cause diarrhoea
so we did not want to give it unless it really did make patients
get better quickly. This study, called a clinical trial, should
have told us whether adding clindamycin is effective and well
tolerated.
The trial recruited over 400 patients with cellulitis and the
majority were able to attend follow up. We found that the addition
of clindamycin did not improve the patients' outcome in any way. We
also found that patient receiving clindamycin for two days had
double the chance of getting diarrhoea. The trial did allow us to
collect very useful information on how quickly patients recover. We
found that many patients were not back to their normal activities
more than a month after getting cellulitis and that this slow
recovery was normal. We hope that this information may stop both
patients and doctors feeling that additional courses of antibiotic
treatment are necessary.
We did a survey of patients' symptoms and their views on what
made things better. This has allowed us to develop another study
which will test things which might make the patient feel better and
find out which ones, if any, do.
Publications
Brindle R, Williams OM, Davies P, et al. Adjunctive clindamycin for
cellulitis: a clinical trial comparing flucloxacillin with or
without clindamycin for the treatment of limb cellulitis. BMJ Open
2017;7: e013260. doi:10.1136/ bmjopen-2016-013260